Modulated Arc Therapy for hippocampal-avoidance whole brain radiation therapy: planning comparison with intensity modulated Radiation Therapy
- 29 May 2024
- journal article
- research article
- Published by Springer Nature in Radiation and Environmental Biophysics
- Vol. 63 (3) , 443-454
Abstract
This study aimed to evaluate the modulated arc therapy (mARC) technique as a planning and treatment option for hippocampal sparing whole brain radiotherapy (HS-WBRT) following the Radiation Therapy Oncology Group (RTOG) 0933 dosimetric criteria. Computed tomography (CT) and magnetic resonance imaging (MRI) were selected retrospectively for 15 patients. Two types of plans were created for each patient, namely an intensity-modulated radiation therapy (IMRT) and a mARC plan. IMRT and mARC plans were compared in terms of plan quality indices, absorbed dose to organs at risk (OARs), number of monitor units (MUs), and treatment time. All plans in both techniques were considered clinically acceptable for treatment. However, IMRT plans presented a higher conformity (p = 0.01) as well as a higher homogeneity as compared to mARC plans, but this difference was not statistically significant (p > 0.05). In terms of the preservation of the hippocampus, it was observed that the IMRT plans achieved significantly lower doses for both 100% of its volume and for its maximum dose (p < 0.001). The evaluation of the remaining OARs showed that the IMRT technique resulted in lower doses, and significant differences were observed for the following organs: left cochlea (p < 0.001), left eye (p < 0.001), right eye (p = 0.03), both lenses of the eye (p < 0.001), and right optic nerve (p = 0.02). Despite these differences, the absolute differences in all dosimetric parameters were low enough to bear any clinical relevance. A drastic (close to 65%) and significant (p < 0.001) decrease was observed in the number of MUs for the mARC plans. This resulted in a substantial decrease in treatment time (60.45%, p < 0.001). It is concluded that the mARC technique is a feasible planning and treatment solution for HS-WBRT that meets the RTOG 0933 criteria. The main advantage of using mARC over IMRT for HS-WBRT is the considerable reduction in MUs and treatment time.Keywords
This publication has 57 references indexed in Scilit:
- Prevention and treatment of radiotherapy‐induced side effectsMolecular Oncology, 2020
- The impact of the field width on VMAT plan quality and the assessment of half field methodJournal of Applied Clinical Medical Physics, 2020
- The posterior cerebellum, a new organ at risk?Clinical and Translational Radiation Oncology, 2018
- Veliparib in combination with whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer: results of a randomized, global, placebo-controlled studyJournal of Neuro-Oncology, 2016
- Dosimetric study of different radiotherapy planning approaches for hippocampal avoidance whole-brain radiation therapy (HA-WBRT) based on fused CT and MRI imagingAustralasian Physics & Engineering Sciences in Medicine, 2015
- VMAT to arclet plan conversion in a treatment planning systemStrahlentherapie und Onkologie, 2015
- Commissioning and first clinical application of mARC treatmentStrahlentherapie und Onkologie, 2014
- Quelle place pour l’irradiation panencéphalique avec épargne des hippocampes ?Cancer/Radiothérapie, 2013
- Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain MetastasesJAMA, 2006
- Neuropsychological effects of cranial radiation: current knowledge and future directionsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995